MCKENZIE DIANA 1754648 Data last updated 2024-05-14 07:02:16 -0500 US CDT

Latest Holdings

Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.


Non-derivative Transactions     CSV download

Tips: type "code_s" to show transactions with code "S".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-06-16 2023-06-14 2023-06-14 4 Mckenzie Diana DIRECTOR acq 147.0 0.95 0.0 53.94 Direct Common Stock METLIFE INC

code_A

code  A
15404.0 765.82 (MET)
2023-06-22 2023-06-20 2023-06-20 4 Mckenzie Diana DIRECTOR acq 803.0 4.95 0.01 54.52 Direct Common Stock METLIFE INC

code_A

code  A
16207.0 765.82 (MET)
2023-09-18 2023-09-14 2023-09-14 4 Mckenzie Diana DIRECTOR acq 128.0 0.78 0.0 65.93 Direct Common Stock METLIFE INC

code_A

code  A
16335.0 752.02 (MET)
2023-10-04 2023-10-02 2023-10-02 4 Mckenzie Diana DIRECTOR acq 710.0 4.17 0.01 61.69 Direct Common Stock METLIFE INC

code_A

code  A
17045.0 752.02 (MET)
2023-12-18 2023-12-14 2023-12-14 4 Mckenzie Diana DIRECTOR acq 132.0 0.77 0.0 66.9 Direct Common Stock METLIFE INC

code_A

code  A
17178.0 740.19 (MET)
2024-01-04 2024-01-02 2024-01-02 4 Mckenzie Diana DIRECTOR acq 650.0 3.65 0.01 67.35 Direct Common Stock METLIFE INC

code_A

code  A
17828.0 740.19 (MET)
2024-03-18 2024-03-14 2024-03-14 4 Mckenzie Diana DIRECTOR acq 129.0 0.72 0.0 71.9 Direct Common Stock METLIFE INC

code_A

code  A
17956.0 723.02 (MET)
2024-04-03 2024-04-01 2024-04-01 4 Mckenzie Diana DIRECTOR acq 594.0 3.2 0.01 73.69 Direct Common Stock METLIFE INC

code_A

code  A
18550.0 723.02 (MET)
2024-05-03 2024-05-01 4 Mckenzie Diana DIRECTOR holding 207.0 0 0.01 0.0 Held In Trust Common Stock VERTEX PHARMACEUTICALS INC / MA

code_

NA
258.31 (VRTX)
2024-05-03 2024-05-01 2024-05-01 4 Mckenzie Diana DIRECTOR acq 1001.0 27.77 0.04 0.0 Direct Common Stock VERTEX PHARMACEUTICALS INC / MA

code_A

code  A
3604.0 258.31 (VRTX)
2024-05-03 2024-05-01 2024-05-01 4 Mckenzie Diana DIRECTOR dsp 1168.0 32.41 0.05 0.0 Direct Common Stock VERTEX PHARMACEUTICALS INC / MA

code_D

code  D
2436.0 258.31 (VRTX)

Derivative Transactions

Tips: type "code_m" to show transactions with code "M".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-07-18 2023-07-14 2023-07-14 4 Mckenzie Diana DIRECTOR acq 89.927 1.93 0.0 350.79 Direct Deferred Stock Units VERTEX PHARMACEUTICALS INC / MA

code_A

code  A
4656.448 257.55 (VRTX)
2023-10-17 2023-10-13 2023-10-13 4 Mckenzie Diana DIRECTOR acq 89.532 1.89 0.0 369.98 Direct Deferred Stock Units VERTEX PHARMACEUTICALS INC / MA

code_A

code  A
4745.98 258.09 (VRTX)
2024-01-17 2024-01-12 2024-01-12 4 Mckenzie Diana DIRECTOR acq 76.503 1.59 0.0 432.99 Direct Deferred Stock Units VERTEX PHARMACEUTICALS INC / MA

code_A

code  A
4822.483 257.68 (VRTX)
2024-05-03 2024-05-01 2024-05-01 4 Mckenzie Diana DIRECTOR acq 1168.0 19.5 0.05 0.0 Direct Deferred Stock Units VERTEX PHARMACEUTICALS INC / MA

code_A

code  A
5990.483 258.31 (VRTX)

a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)